[1]ANDRÉ S,ANDREOZZI F,VAN OVERSTRAETEN C,et al. Cardiometabolic comorbidities in obstructive sleep apnea patients are related to disease severity,nocturnal hypoxemia,and decreased sleep quality[J/OL]. Respir Res,2020,21(1):35[2023-04-02]. https://doi.org/10.1186/s12931-020-1284-7.
[2]DYKEN M E,IM K B. Obstructive sleep apnea and stroke[J]. Chest,2009,136(6):1668-1677.
[3]GUILLEMINAULT C,TILKIAN A,DEMENT W C. The sleep apnea syndromes[J/OL]. Annu Rev Med,1976,27:465-484[2023-04-02]. https://doi.org/10.1146/annurev.me.27.020176.002341.
[4]IP M S,LAM B,CHAN L Y,et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure[J]. Am J Respir Crit Care Med,2000,162(6):2166-2171.
[5]RYAN S,TAYLOR C T,MCNICHOLAS W T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome[J]. Circulation,2005,112(17):2660-2667.
[6]JURADO-GAMEZ B,GOMEZ-CHAPARRO J L,MUÑOZ-CALERO M,et al. Serum proteomic changes in adults with obstructive sleep apnoea[J]. J Sleep Res,2012,21(2):139-146.
[7]WALLDIUS G,JUNGNER I. Apolipoprotein B and apolipoprotein A-I:risk indicators of coronary heart disease and targets for lipid-modifying therapy[J]. J Intern Med,2004,255(2):188-205.
[8]XU H J,GUAN J,YI H L,et al. Elevated low-density lipoprotein cholesterol is independently associated with obstructive sleep apnea:evidence from a large-scale cross-sectional study[J]. Sleep Breath,2016,20(2):627-634.
[9]CAO B,FAN Z Q,ZHANG Y H,et al. Independent association of severity of obstructive sleep apnea with lipid metabolism of atherogenic index of plasma(AIP)and apoB/apoAI ratio[J]. Sleep Breath,2020,24(4):1507-1513.
[10]HELLMAN N E,GITLIN J D. Ceruloplasmin metabolism and function[J/OL]. Annu Rev Nutr,2002,22:439-458[2023-04-02]. https://doi.org/10.1146/annurev.nutr.22.012502.114457.
[11]VAIDYA S M,KAMALAKAR P L. Copper and ceruloplasmin levels in serum of women with breast cancer[J]. Indian J Med Sci,1998,52(5):184-187.
[12]LAVIE L,LAVIE P. Smoking interacts with sleep apnea to increase cardiovascular risk[J]. Sleep Med,2008,9(3):247-253.
[13]COX C,TEKNOS T N,BARRIOS M,et al. The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma[J/OL]. Laryngoscope,2001,111(4 Pt 1):696-701[2023-04-02]. https://doi.org/10.1097/00005537-200104000-00024.
[14]OZCELIK F,ERDOGAN O,AKTOZ M,et al. Diagnostic value of plasma fibronectin level in predicting the presence and severity of coronary artery disease[J]. Ann Hematol,2009,88(3):249-253.
[15]OREM C,DURMUŞ I,KILINÇ K,et al. Plasma fibronectin level and its association with coronary artery disease and carotid intima-media thickness[J]. Coron Artery Dis,2003,14(3):219-224.
[16]STENMAN S,VON SMITTEN K,VAHERI A. Fibronectin and atherosclerosis[J/OL]. Acta Med Scand Suppl,1980,642:165-170[2023-04-02]. https://doi.org/10.1111/j.0954-6820.1980.tb10949.x.
[17]ZHANG H N,YANG F,GUO Y C,et al. The contribution of chronic intermittent hypoxia to OSAHS:from the perspective of serum extracellular microvesicle proteins[J/OL]. Metabolism,2018,85:97-108[2023-04-02]. https://doi.org/10.1016/j.metabol.2018.02.012.
[18]ZHANG Y N,WU X D,SUN Q Q,et al. Biomarkers and dynamic cerebral autoregulation of obstructive sleep apnea-hypopnea syndrome[J/OL]. Nat Sci Sleep,2021,13:2019-2028[2023-04-02]. https://doi.org/10.2147/NSS.S328348.
[19]HOPPS E,CANINO B,MONTANA M,et al. Gelatinases and their tissue inhibitors in a group of subjects with obstructive sleep apnea syndrome[J]. Clin Hemorheol Microcirc,2016,62(1):27-34.
[20]沈恺妮,李剑. 原发性轻链型淀粉样变的治疗进展[J]. 中国实验血液学杂志,2015,23(3):910-914.
[21]HARRIS-TRYON T A,GRICE E A. Microbiota and maintenance of skin barrier function[J]. Science,2022,376(6596):940-945.
[22]JURADO-GÁMEZ B,FERNANDEZ-MARIN M C,GÓMEZ-CHAPARRO J L,et al. Relationship of oxidative stress and endothelial dysfunction in sleep apnoea[J]. Eur Respir J,2011,37(4):873-879.
[23]温伟生,胡敏,柳春明,等. 不同体位下软腭位置与腭后气道的相关性研究[J]. 军医进修学院学报,2001,22(1):57-59.
[24]杨怀安,刘艾竹,李赛楠,等. 不同程度OSAHS患者腭咽软组织病理形态学改变[J]. 临床耳鼻咽喉头颈外科杂志,2012,26(24):1119-1122,1126.
[25]RYAN S,TAYLOR C T,MCNICHOLAS W T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome[J]. Circulation,2005,112(17):2660-2667.
[26]MAKINO S,FUJIWARA M,SUZUKAWA K,et al. Visceral obesity is associated with the metabolic syndrome and elevated plasma retinol binding protein-4 level in obstructive sleep apnea syndrome[J]. Horm Metab Res,2009,41(3):221-226.
[27]PERES B U,ALLEN A J H,KENDZERSKA T,et al. Obstructive sleep apnea severity,body mass index,and circulating levels of cellular adhesion molecules[J]. Lung,2020,198(6):939-945.
[28]SUN H L,DU Y H,ZHANG L C,et al. Increasing circulating ESM-1 and adhesion molecules are associated with earlystage atherosclerosis in OSA patients:a cross-sectional study[J/OL]. Sleep Med,2022,98:114-120[2023-04-02]. https://doi.org/10.1016/j.sleep.2022.06.015.
[29]TIAN Z S,XIAO J Y,KANG J,et al. Effects of continuous positive airway pressure on cell adhesion molecules in patients with obstructive sleep apnea:a meta-analysis[J]. Lung,2021,199(6):639-651.
[30]BAGAI K,MULDOWNEY J A,SONG Y,et al. Circadian variability of fibrinolytic markers and endothelial function in patients with obstructive sleep apnea[J]. Sleep,2014,37(2):359-367.
[31]IFERGANE G,OVANYAN A,TOLEDANO R,et al. Obstructive sleep apnea in acute stroke:a role for systemic inflammation[J]. Stroke,2016,47(5):1207-1212.
[32]BADRAN M,GOZAL D. PAI-1:a major player in the vascular dysfunction in obstructive sleep apnea?[J]. Int J Mol Sci,2022,23(10):5516[2023-04-02]. https://doi.org/10.3390/ijms23105516.